Is supplementary iron useful when preterm infants are treated with erythropoietin?

Archives of Disease in Childhood

Volumn 91, Issue 12, 2006, Pages 1036-1038

  Ridley, F C ^a   Harris, J ^a   Gottstein, R ^a   Emmerson, A J B ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MEGADOSE; ERYTHROPOIESIS; HUMAN; INFANT; IRON DEPLETION; IRON STORAGE; IRON THERAPY; LOW DRUG DOSE; NEWBORN ANEMIA; NOTE; PREMATURITY; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANEMIA, NEONATAL; DIETARY SUPPLEMENTS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INFANT, NEWBORN; IRON;

EID: 33845267422     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.105205     Document Type: Note

References (12)

1. Camielli VP, Da Riol R, Montini G. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998;79:F44-8.
2. Fujiu T, Maruyama K, Koizumi T. Oral iron supplementation in preterm infants treated with erythropoietin. Pediatr Int 2004;46:635-9.
3. Kivivuori SM, Virtanen M, Raivio KO, et al. Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants. Eur J Pediatr 1999;158:147-51.
4. Meyer MP, Haworth C, Meyer JH, et al. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 1996;129:258-63.
5. Bader D, Kugelman A, Maor-Rogin N, et al. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity. J Perinatol 2001;21:215-20.
6. Nazir S, Peverini RL, Deming DD, et al. Comparison of 2 iron doses in infants receiving recombinant human erythropoeitin therapy. Arch Pediatr Adolesc Med 2002;156:540-4.
7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 1990;17:1-12.
8. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birthweight preterm infants. Pediatrics 1995;95:1-8.
9. Soubasi V, Kremenopoulos G, Diamandi E, et al. In which neonates does early recombinant erythropoetin treatment prevent anemia of prematurity? Results of a randomised controlled study. Pediatr Res 1993;34:675-9.
10. Franz AR, Mihatsch WA, Sander S, et al. Prospective randomised trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams. Pediatrics 2000;106:700-6.
11. Jansson L, Holmberg L, Nilsson B, et al. Vitamin E requirements of preterm infants. Acta Paediatr Scand 1978;67:459-63.
12. Pollak A, Hayde M, Hayn M, et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics 2001;107:78-65.